Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nightingale Health

Explore full profile

A blood testing company bringing extensive biological data to routine healthcare

Helsinki, FinlandFounded 2013Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2026
Revenue $1–10M Latest reported FY
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Nightingale Health and the history behind them.

About Nightingale Health

Nightingale Health provides a comprehensive health data platform that focuses on preventative healthcare. The company has developed a proprietary blood analysis technology that delivers biomarker data from a single blood sample. This technology is utilized to provide health checks and risk prediction models for chronic diseases.

Read full description

The company's strategy is centered on the business-to-business (B2B) and business-to-government (B2G) markets. In the B2B sector, Nightingale Health collaborates with private healthcare providers, such as Terveystalo in occupational health, to integrate its technology into their services. The B2G approach involves partnerships with public healthcare systems to implement preventative health initiatives.

Nightingale Health's business model is driven by the global trends of increasing consumer investment in health and wellbeing, the rising prevalence of chronic diseases, and the growing strain on traditional healthcare systems. The company's revenue is generated by providing its advanced health check and data analysis services to its partners in the private and public sectors.

Source: Dealroom company data

At a glance

Founded
2013
Headquarters
Helsinki, Finland
Sector
Biotech & Life Sciences

Latest news

Press, funding announcements and product moves mentioning Nightingale Health.

See all news

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

  • Cor Group
  • StartUp Health
  • Mikko Kodisoja
  • Markku Kaloniemi
  • Leena Niemistö
  • Timo Soininen

Series A4 investors entered at this stage

Series B and later4 investors entered at this stage

  • PerkinElmer
  • European Investment Bank
  • Mitsui Global Investment
  • Kirin
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States2.5%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nightingale Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nightingale Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.